Clinical Trials Logo

Metabolic Health clinical trials

View clinical trials related to Metabolic Health.

Filter by:

NCT ID: NCT05291065 Recruiting - Appetitive Behavior Clinical Trials

Breakfast, Exercise and Metabolic Health in Healthy Men

Start date: March 13, 2022
Phase: N/A
Study type: Interventional

This project aims to investigate the impact of acute bout of submaximal exercise under different pre-exercise dietary conditions (fasted state versus high carbohydrate breakfast versus high protein breakfast) on postprandial glycaemic, appetite regulation and energy balance.

NCT ID: NCT04389736 Completed - Energy Expenditure Clinical Trials

Effects of NMES on Energy Expenditure, Glycaemia and Hormonal Responses to Glucose Ingestion

Start date: November 27, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether self-selected neuromuscular stimulation (NMES) affects energy expenditure, glycaemia and hormonal responses in healthy men and women

NCT ID: NCT03969745 Completed - Metabolic Health Clinical Trials

Effects of Two-weeks of Time Restricted Feeding on Basal and Postprandial Metabolism in Healthy Men

TRF
Start date: June 26, 2017
Phase: N/A
Study type: Interventional

In the modern era, food access is widely available and it is not uncommon for the time between breakfast and a late night snack to exceed 14 hours. The investigators are interested in studying whether limiting this window to 8 hours will have any beneficial effects of human health as has been demonstrated in animal models. Eight men were asked to restrict their energy intake window to between 8 am and 4 pm for two weeks whilst maintaining their habitual diet (quantity and composition). Improvements in skeletal muscle and whole-body insulin sensitivity were observed but these were potentially confounded by an average weight loss of 1 kg. Therefore an additional control group was recruited to follow a daily caloric deficit of ~400 kilocalories without changing the timing of intake.

NCT ID: NCT03842514 Completed - Gut Health Clinical Trials

Food Additives - Do Processed Diets Impact on Gut and Metabolic Health

FADiets
Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This dietary intervention study will assess the effect in healthy human volunteers of an E number which is a food additive and commonly used and consumed emulsifier, on gut function, gut inflammation and glucose metabolism. We will be using a powdered soy lecithin product in the food to compare a diet with and without this ingredient.

NCT ID: NCT03670524 Recruiting - Clinical trials for Cardiovascular Diseases

Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project

HEAL
Start date: May 3, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.

NCT ID: NCT03082131 Completed - Gut Microbiota Clinical Trials

Resistant Starch Wheat for Improved Metabolic Health

Start date: May 22, 2017
Phase: N/A
Study type: Interventional

The objective of this study is to determine the effect of wheat enriched in resistant starch (RS) on the generation of fermentation products by the lower gut microbes, the fecal microbiota profile, intestinal metabolites, and the glycemic response to a test meal compared to regular wheat.

NCT ID: NCT02585336 Completed - Metabolic Health Clinical Trials

Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly

IMPROVE
Start date: July 28, 2015
Phase: N/A
Study type: Interventional

Sugar-sweetened beverages (SSBs) have been epidemiologically linked to serious health problems including heart disease, liver disease, and diabetes. This study will recruit frequent SSB drinkers who are employees at the University of California, San Francisco (UCSF) and measure markers of metabolic health on two occasions, 10 months apart. During this time, UCSF will cease selling SSBs at all campus and medical center locations. Additionally, at the first assessment half of participants will be randomly assigned to a brief intervention to help reduce SSB consumption, consisting of a 10-20 minute semi-structured interview designed to share health information about SSBs, elicit motivations to reduce consumption, and help set concrete plans to reduce consumption. The investigators will be able to compare changes in metabolic health among those who do and do not reduce SSB consumption. This will make a unique contribution to the growing evidence regarding both the effects of SSB consumption on health and the modifiability of SSB-related health conditions.

NCT ID: NCT01767051 Completed - Clinical trials for Cardiovascular Health

Children Follow-up of PCOS Women

CHOPS
Start date: November 2012
Phase: N/A
Study type: Observational

Polycystic ovary syndrome (PCOS) is a complex and frequent disorder with a heterogeneous clinical presentation varying throughout life, from birth up to post-menopause. Although mostly known for its reproductive consequences, PCOS is associated with metabolic abnormalities related to insulin resistance and obesity. Children born from PCOS mothers are considered to be at risk for early insulin resistance, leading to development of PCOS and metabolic abnormalities in childhood and adolescence. Obesity and insulin resistance are considered as states of low- and pro-inflammation associated with endothelial dysfunction. In addition, it has been shown that endothelial dysfunction develops from the first decade of life in response to genetic and environmental risk factors. Therefore, offspring of women with PCOS may be at increased risk for vascular disease later in life. Moreover, some evidence suggests that early life respiratory disease also contributes to later life cardiovascular consequences. The number of studies on offspring of PCOS mothers is low and a systematic follow up of children born form PCOS mothers has not been performed yet. the investigators propose a systematic evaluation of cardiometabolic and pulmonary health characteristics of children (aged 2,5-8 years) born from mothers diagnosed with PCOS. A saliva sample will be performed to determine the biochemical androgenic status of the children. Mothers of these children have undergone standardized phenotyping prior to conception; the investigators will therefore be able to correlate the metabolic status of the mother around the time of conception and the cardiometabolic and pulmonary health of their offspring.